# Stryker Corporation (SYK) — Q1-2026 Earnings Results

**Report date:** 2026-04-30 (after market close)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/SYK/earnings/Q1-2026

## Analyst Estimates

- **Consensus EPS:** $2.98 (range $2.86–$3.07)
- **Consensus revenue:** $6329.45

## Post-Earnings Brief

### Headline

Stryker Corporation Misses on EPS, Stock Up 0.00%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.60 | $2.98 | -12.63% |
| Revenue | N/A | $6.3B | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record for this earnings call, so the analysis is based solely on the numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Stryker Corporation reported earnings that fell short of analyst expectations, particularly in EPS. Despite the miss, the stock showed no movement, remaining stable. Investors may be awaiting further insights from future earnings calls or additional guidance.

## Pre-Earnings Brief

### Company Snapshot

Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative healthcare equipment. Operating in the health care sector, Stryker focuses on products that enhance surgical outcomes and improve patient care, making it a significant player in the medical device industry.

### Key Metrics to Watch

- **EPS** (consensus $2.98) — Earnings per share is a key indicator of profitability and will show how well Stryker is managing costs and generating income.
- **Revenue** (consensus $6.3B) — Total revenue reflects the company's sales performance and market demand for its products, which is crucial for assessing growth.

### Last Quarter Recap

In Q4-2025, Stryker reported an EPS of $4.47, beating estimates by 1.71%. However, the stock experienced a slight decline of 0.99% the following day.

### Wall Street Expectations

Analysts expect Stryker to continue its trend of exceeding earnings expectations, with a consensus EPS of $2.98 and revenue of $6.3B. The market is closely watching for any signs of growth in demand for its products.

**Bull case:** If Stryker beats earnings expectations again, it could indicate strong operational efficiency and demand, potentially driving the stock higher as investors gain confidence in its growth trajectory.

**Bear case:** Conversely, if Stryker fails to meet expectations, it may raise concerns about market demand and profitability, leading to a negative reaction from investors.

### Options Signal

Implied move: **6.51%**

The options market is pricing in a significant move around the earnings report, suggesting that traders expect volatility based on the upcoming results.

### Earnings Track Record

| Quarter | EPS Surprise | 1-Day Reaction |
|---|---|---|
| Q4-2025 | +1.71% | -0.99% |
| Q3-2025 | +1.66% | -0.17% |
| Q2-2025 | +2.05% | -1.92% |
| Q1-2025 | +4.18% | +0.02% |
| Q4-2024 | +3.51% | -1.19% |

### Pivotal Questions

1. **Will Stryker's EPS exceed the consensus estimate of $2.98?**
   - Why it matters: A beat on EPS would reinforce Stryker's strong operational performance and could boost investor confidence.
2. **What are the revenue growth prospects for Stryker's key product lines?**
   - Why it matters: Understanding revenue growth will provide insight into market demand and the company's competitive position in the healthcare equipment sector.

### Thesis Break Levels

- **Bull trigger:** An EPS of $3.05 or higher would confirm the bull case, indicating strong demand and cost management.
- **Bear trigger:** An EPS below $2.86 would confirm the bear case, suggesting potential issues with profitability or market demand.

This quarter, the focus is on Stryker's ability to maintain its growth trajectory amid competitive pressures and market dynamics.

### Scenario Playbook

- **Beat & raise:** If Stryker beats expectations, history suggests the stock could rise by about 0.84%, confirming strong operational performance.
- **In-line / cautious:** An inline result may lead to a muted reaction, as investors await further guidance on future growth.
- **Miss:** If Stryker misses expectations, the stock could decline, with historical patterns suggesting a potential drop of around 0.63%.

### What the Street is Missing

The Street may underestimate Stryker's ability to leverage its innovative product pipeline, which could lead to stronger-than-expected revenue growth this quarter.

**Supporting points:**

- Stryker has consistently beaten EPS estimates in the past, indicating strong operational execution.
- The options market is pricing in a larger move than historical averages, suggesting that traders expect significant news.
- Recent insider trading activity shows mixed signals, which may indicate uncertainty about future performance.

**Risk to consensus:** If Stryker's revenue growth exceeds $6.5B, it could challenge the current cautious consensus.

### What to Listen For

- Any updates on new product launches and their expected impact on revenue.
- Management's commentary on market demand and competitive landscape.
- Insights into cost management strategies and their effect on margins.
- Guidance on future revenue growth and any changes to long-term targets.
- Responses to questions regarding supply chain challenges and their impact on operations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/SYK/earnings/Q1-2026_